Simplex Trading’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-48
Closed 9939
2024
Q3
$0 Buy
+48
New +$320 ﹤0.01% 9844
2022
Q4
Sell
-33
Closed 10729
2022
Q3
$0 Buy
33
+30
+1,000% +$564 ﹤0.01% 11114
2022
Q2
$0 Sell
3
-194
-98% -$5.4K ﹤0.01% 11373
2022
Q1
$6K Sell
197
-250
-56% -$7.6K ﹤0.01% 9341
2021
Q4
$12K Sell
447
-452
-50% -$17.7K ﹤0.01% 8891
2021
Q3
$44K Hold
899
﹤0.01% 7668
2021
Q2
$45K Buy
+899
New +$45.3K ﹤0.01% 7782

Simplex Trading's ORGS Position: Q4 2024 in Review

Simplex Trading sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 48 shares.

Simplex Trading first reported a position in ORGS in Q2 2021 and held it in 7 quarters. The position peaked at $45K in Q2 2021. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.

  • Simplex Trading reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 48 Orgenesis Inc. Common Stock shares in Q4 2024.
  • Simplex Trading first reported a position in Orgenesis Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Simplex Trading's Orgenesis Inc. Common Stock position peaked at $45K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.